Menta Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Menta Capital’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,380	Closed	-$432K	–	549
2018 Q3	$432K	Sell	1,380 -3	-0.2%	-$931	0.15%	254
2018 Q2	$399K	Sell	1,383 -57	-4%	-$15.7K	0.09%	393
2018 Q1	$360K	Sell	1,440 -1,062	-42%	-$270K	0.08%	423
2017 Q4	$597K	Sell	2,502 -1,741	-41%	-$422K	0.12%	316
2017 Q3	$943K	Sell	4,243 -2,920	-41%	-$657K	0.14%	271
2017 Q2	$1.62M	Buy	7,163 +1,196	+20%	+$261K	0.19%	186
2017 Q1	$1.19M	Buy	+5,967	New	+$1.15M	0.12%	294
2015 Q1	–	Sell	-7,660	Closed	-$923K	–	691
2014 Q4	$923K	Buy	+7,660	New	+$882K	0.13%	273

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Menta Capital's BIO Position: Q4 2018 in Review

Menta Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2018, closing a stake of 1,380 shares — an estimated $432K sold.

Menta Capital first reported a position in BIO in Q4 2014 and held it in 8 quarters. The position peaked at $1.62M in Q2 2017. 329 funds tracked by Wall St. Rank hold BIO as of Q4 2018.

Menta Capital reported no remaining Bio-Rad Laboratories Class A position as of Q4 2018 after selling out during the quarter.
Menta Capital sold 1,380 Bio-Rad Laboratories Class A shares in Q4 2018, an estimated $432K.
Menta Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 8 quarters.
Menta Capital's Bio-Rad Laboratories Class A position peaked at $1.62M in Q2 2017.
329 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2018.

Based on Menta Capital's 13F filing for Q4 2018, filed 14 Feb 2019.